Journal of Hematology & Oncology is an open access, peer-reviewed online journal that encompasses all aspects of hematology and oncology. Read more.
Collections open for submissions
- Latest updates from major conferences
- First-ever clinical trials
- New developments in delivery technology, materials, and molecular engineering for drug discovery
This Journal of Hematology & Oncology and Experimental Hematology & Oncology series intends to publish Correspondences with latest updates on novel agents and regimens from major conferences on blood and cancer disorders. Each Correspondence serves as a summary and analysis of 5 or more abstracts on a similar focus from a major international conference.
This series calls for clinical studies on novel agents for cancers and blood disorders. Summaries and reviews on first-in-human or first-in-class studies are also welcome.
This series covers new technology, materials, and models for drug discovery. Development and applications of organoids, 3D cultures, PDX modes, nano-molecules, AI technology, and single-cell maps for drug discovery will be the focus.
Aims and scope
In recognition of Blood Cancer Awareness Month, this September, Editors from across our hybrid and OA oncology journals have chosen a compilation of articles to highlight the latest advances in blood cancer research.
Experimental Hematology & Oncology
Submit your research to our companion journal, Experimental Hematology & Oncology.
The Chinese American Hematologist and Oncologist Network (CAHON) has published an important and timely Editorial in the Journal of Hematology & Oncology. We are proud to stand with them in denouncing in the strongest terms all forms of discrimination and crimes against any racial/ethnic group, including Asian Americans and Pacific Islanders, and to call on our readers to pursue racial equality and tolerance in the USA and beyond.
"Journal of Hematology & Oncology provides a forum for top-quality research and is a leading title in hematology and oncology, with an Impact Factor ranked in Q1 in both categories. The journal also publishes reviews and research highlights from leading experts in the field. Research is shared with fast turnaround times in an open access format among laboratory scientists, physician scientists, hematologists and oncologists."
Prof Delong Liu, Editor-in-Chief, Journal of Hematology & Oncology
Official journal of
Journal of Hematology & Oncology is the official journal of the Chinese American Hematologist and Oncologist Network.
- Editorial Board
- Manuscript editing services
- Instructions for Editors
- Instructions for authors
- Sign up for article alerts and news from this journal
Annual Journal Metrics
2022 Citation Impact
28.5 - 2-year Impact Factor
23.1 - 5-year Impact Factor
4.045 - SNIP (Source Normalized Impact per Paper)
6.046 - SJR (SCImago Journal Rank)
5 days submission to first editorial decision for all manuscripts (Median)
74 days submission to accept (Median)
9,883 Altmetric mentions
On the blog
06 April 2023
Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).